MARKET

NBTX

NBTX

Nanobiotix S.A.
NASDAQ
5.50
+0.12
+2.23%
After Hours: 5.54 +0.04 +0.73% 17:47 04/18 EDT
OPEN
5.54
PREV CLOSE
5.38
HIGH
5.54
LOW
5.31
VOLUME
28.36K
TURNOVER
0
52 WEEK HIGH
11.00
52 WEEK LOW
1.750
MARKET CAP
259.23M
P/E (TTM)
-2.9963
1D
5D
1M
3M
1Y
5Y
Nanobiotix Sa ADR Sets Q4 and Full Year Results Date
TipRanks · 1d ago
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
NANOBIOTIX will report its financial and operational results for the fourth quarter and full year ended December 31, 2023, on April 24, 2024. The company is a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for cancer patients.
Barchart · 1d ago
Weekly Report: what happened at NBTX last week (0408-0412)?
Weekly Report · 3d ago
CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Shares of CarMax, Inc. Fell sharply in today’s pre-market trading after the company reported lower-than-expected fourth-quarter earnings. CarMax shares dipped 9.1% to $72.06 in pre- market trading. The Lovesac Company shares fell 13% after reporting worse- than-expected results. The Dow futures fell over 150 points on Thursday.
Benzinga · 04/11 12:03
Nanobiotix Sa ADR Updates Share Capital Info
TipRanks · 04/11 08:40
Voting Rights and Shares Capital of the Company
Barchart · 04/10 15:15
Weekly Report: what happened at NBTX last week (0401-0405)?
Weekly Report · 04/08 09:24
Nanobiotix Advances NBTXR3 for Lung Cancer Treatment
TipRanks · 04/02 20:58
More
About NBTX
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.

Webull offers Nanobiotix SA - ADR stock information, including NASDAQ: NBTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NBTX stock methods without spending real money on the virtual paper trading platform.